TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
Public ClinicalTrials.gov record NCT03093701. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT03093701
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Taiwan Liposome Company
- Industry
- Enrollment
- 31 participants
Conditions and interventions
Conditions
Interventions
- TLC399 (ProDex) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2017
- Primary completion
- Feb 3, 2019
- Completion
- Feb 3, 2019
- Last update posted
- Dec 22, 2021
2017 – 2019
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retinal Research Institute | Phoenix | Arizona | 85014 | — |
| Retina Institute of California | Arcadia | California | 91007 | — |
| Retina-Vitreous Associates Medical Group | Beverly Hills | California | 90211 | — |
| Retina Institute of California | Palm Desert | California | 92260 | — |
| Colorado Retina Associates | Golden | Colorado | 80401 | — |
| Retina Group of New England | New London | Connecticut | 09320 | — |
| Retina Macula Specialists of Miami | Miami | Florida | 33126 | — |
| Georgia Retina, P.C | Marietta | Georgia | 30060 | — |
| Ophthalmic Consultants of Boston | Boston | Massachusetts | 02114 | — |
| Retina Consultants of Nevada | Las Vegas | Nevada | 89149 | — |
| Retina Associates of Western New York, PC | Rochester | New York | 14620 | — |
| Charlotte Eye Ear Nose & Throat Assoc, PA | Charlotte | North Carolina | 28210 | — |
| The Cleveland Clinic | Cleveland | Ohio | 44915 | — |
| Retina Research Institute of Texas | Abilene | Texas | 79606 | — |
| Retina Research Center | Austin | Texas | 78705 | — |
| Retina Consultants of Houston | Houston | Texas | 77030 | — |
| Medical Center Ophthalmology Associates | San Antonio | Texas | 78240 | — |
| Retinal Consultants of San Antonio | San Antonio | Texas | 78240 | — |
| Retina Consultants of Houston,The Woodlands | The Woodlands | Texas | 77384 | — |
| University of Virginia | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03093701, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2021 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03093701 live on ClinicalTrials.gov.